Trevi Therapeutics (NASDAQ:TRVI) Stock Price Expected to Rise, HC Wainwright Analyst Says
Trevi Therapeutics (NASDAQ:TRVI – Free Report) had its price target increased by HC Wainwright from $7.50 to $12.50 in a report published on Monday,Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities analysts have also issued reports on the stock. Needham & Company LLC raised their target […]
Trevi Therapeutics (NASDAQ:TRVI – Free Report) had its price target increased by HC Wainwright from $7.50 to $12.50 in a report published on Monday,Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities analysts have also issued reports on the stock. Needham & Company LLC raised their target […]
